Dr Shahin Gharakhanian is the founder of the Boston-Paris Biotechnology Summit. Shahin specializes in Drug & Vaccine Clinical Development Medical Affairs. He has expertise in Pharmaceutical Medicine, Executive Leadership & Management. He is principal/founder of Shahin Gharakhanian MD Consulting LLC, based @ the Cambridge Innovation Center, a US/EU network of experts, focused on novel drugs & vaccines development strategy and clinical trials as well as scientific affairs. Since 2011, his group has collaborated globally with BIONOR Pharma (Norway), GENZYME Corporation (USA), DaVolterra (France), Exl Pharma (USA), InnaVirVax (France), GSK/ViiV Healthcare (USA), NOVARTIS (Switzerland & USA), NovoBioPharma (co-founder, USA), Metys Pharma (Switzerland), ORCHARD Therapeutics (UK), Transgene (France), Versantis (Switzerland), VCLS (France). In BOSTON, his most recent corporate position was Vice-President, Medical Affairs/Medicines Development Group, Global R&D, VERTEX Pharmaceuticals, Inc. Overall, Shahin has managed or led projects for 12 different companies, ten different brands and four drug launches, in different therapeutic areas and geographic regions [Asia, USA, EU]. Shahin co-founded the French-American Biotech Spring Board (FABS) in Boston/Cambridge MA. He trained in Internal Medicine & Infectious Diseases, practiced Medicine for more than 20 years in AP-HP Hospitals in Paris, Assistance Publique – Hopitaux de Paris. His CME, for over ten years, is carried out at Harvard Medical School Programs, Boston, USA.